Health Condition 1: C15-C26- Malignant neoplasms of digestive organs Health Condition 2: K20-K31- Diseases of esophagus, stomach and duodenum Health Condition 3: K50-K52- Noninfective enteritis and colitis Health Condition 4: K80-K87- Disorders of gallbladder, biliary tract and pancreas Health Condition 5: K55-K64- Other diseases of intestines Health Condition 6: K35-K38- Diseases of appendix Health Condition 7: K42- Umbilical hernia Health Condition 8: K43- Ventral hernia Health Condition 9: N1
Conditions
Interventions
Intervention1: Application of shallow neuromuscular blockade in major abdominal surgeries.: Pre operative diaphragmatic thickness fraction will be monitored
Induction dose of Atracurium will be giv
Sponsors
All India Institute of Medical Sciences, New Delhi
Eligibility
Inclusion criteria
Inclusion criteria: Patients undergoing major abdominal surgery with an expected duration of at least 2 hours.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the effect of shallow vs moderate neuromuscular blockade on post operative diaphragmatic thickness fraction 60 minutes after extubation in patients undergoing major abdominal surgery with an expected duration of at least 2 hours.Timepoint: To compare the effect of shallow vs moderate neuromuscular blockade on post operative diaphragmatic thickness fraction 60 minutes after extubation in patients undergoing major abdominal surgery with an expected duration of at least 2 hours. | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess the the effect of shallow vs moderate neuromuscular blockade on post operative lung ultrasound score & DETimepoint: 60 minutes after extubation;To assess the incidence of POPCTimepoint: POD 3;To assess patient centred outcomes like duration of ICU stay and hospital stayTimepoint: Post operative Hospital stay | — |
Countries
India
Contacts
Public ContactArju Choudhary
AIIMS New Delhi
Outcome results
None listed